Edition:
India

Akebia Therapeutics Inc (AKBA.OQ)

AKBA.OQ on NASDAQ Stock Exchange Global Market

10.23USD
11:24pm IST
Change (% chg)

$-0.06 (-0.58%)
Prev Close
$10.29
Open
$10.25
Day's High
$10.39
Day's Low
$10.16
Volume
40,147
Avg. Vol
184,843
52-wk High
$20.25
52-wk Low
$7.90

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.46 December 23 Jul 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 2 2
(2) OUTPERFORM 5 5 5 5
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 1.88 1.88

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 7 52.02 65.00 40.00 28.00
Quarter Ending Dec-18 7 67.88 90.00 45.46 38.00
Year Ending Dec-18 7 215.57 240.93 182.79 135.33
Year Ending Dec-19 7 300.36 490.50 170.00 165.67
Earnings (per share)
Quarter Ending Sep-18 6 -0.46 -0.25 -0.62 -0.50
Quarter Ending Dec-18 6 -0.26 0.22 -0.60 -0.27
Year Ending Dec-18 6 -1.60 -1.11 -2.24 -2.77
Year Ending Dec-19 7 -1.30 0.21 -5.07 -0.68

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 46.12 45.93 0.19 0.42
Quarter Ending Dec-17 48.56 87.32 38.76 79.82
Quarter Ending Sep-17 37.05 41.28 4.23 11.43
Quarter Ending Jun-17 26.46 28.52 2.06 7.79
Quarter Ending Mar-17 21.47 20.86 0.60 2.80

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 52.02 52.02 51.54 53.87 28.00
Quarter Ending Dec-18 67.88 67.88 62.16 64.92 38.00
Year Ending Dec-18 215.57 215.57 209.40 215.75 135.33
Year Ending Dec-19 300.36 300.36 218.53 218.53 165.67

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 1 0
Year Ending Dec-18 0 0 1 0
Year Ending Dec-19 0 0 3 0
Earnings